ROXITHROMYCINE SANDOZ 150 mg, film-coated tablet scored 10 tablets
Active ingredients: Roxithromycin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet scored10 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ROXITHROMYCINE SANDOZ 150 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 10 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jul 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64026666CIP73609144CIP133400936091443Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROXITHROMYCINEcomprimé | 150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.